logo

For the Inventor, By the Inventor

Tsukuba, Japan

Masanori Okamoto

This inventor holds 17 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1981-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanori Okamoto. Retrieved from https://idiyas.com/inventor/masanori-okamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Tsukuba, JP (1990 - 1995)
  • Osaka, JP (1981 - 2000)

Company Filing History:

goldMedal17 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1981-2000

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6110933 - Amino acid derivatives and their use as phospholipase A.sub.2 inhibitor (2000-08-29),
2. 5409701 - FR901451 substance, process for preparation thereof and use thereof (1995-04-25),
3. 5364624 - WS7622A mono- or di-sulfate, process for preparation thereof and use (1994-11-15),
4. 5292510 - WS7622A mono- or di- sulfate, process for preparation thereof and use (1994-03-08),
5. 5279826 - Prophylactic/therapeutic composition for disseminated intravascular (1994-01-18),
6. 5167958 - WS7622A, B, C and D substances, derivatives thereof, processes for (1992-12-01),
7. 5098927 - Antiretroviral agent, method of use thereas, and method of preparation (1992-03-24),
8. 5043354 - Pharmaceutically useful 5-hydroxy-2,3-dihydro-benzofurans and (1991-08-27),
9. 5021240 - WS7622A, B, C and D substances, derivatives thereof, processes for (1991-06-04),
10. 4963585 - Compound, WF11605 and derivative thereof (1990-10-16),
11. 4863926 - Nitro aliphatic compounds, process for preparation thereof and use (1989-09-05),
12. 4797417 - Furanone derivatives, process for preparation thereof and use thereof (1989-01-10),
13. 4782088 - Nitro aliphatic compounds and use thereof (1988-11-01),
14. 4778804 - Nitro aliphatic compounds, process for preparation thereof and use (1988-10-18),
15. 4767768 - Nitro aliphatic compounds, process for preparation thereof and use (1988-08-30),

Title: **Masanori Okamoto: Innovator in Pharmaceutical Patents**

Introduction

Masanori Okamoto, a notable inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With an impressive portfolio of 17 patents, Okamoto continues to push the boundaries of pharmaceutical sciences, showcasing his expertise and creativity.

Latest Patents

Among his latest achievements, Okamoto has been involved in the development of amino acid derivatives, which serve as phospholipase A₂ inhibitors. His recent patent, titled "FR901451 substance, process for preparation thereof and use thereof," indicates his ongoing commitment to finding novel solutions in medicine. These breakthroughs highlight the importance of his work in addressing various health concerns through innovative chemical applications.

Career Highlights

Masanori Okamoto is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he applies his knowledge and skills to lead research initiatives and product development. His role at Fujisawa has allowed him to work on groundbreaking projects that enhance therapeutic options for patients worldwide.

Collaborations

Throughout his career, Okamoto has collaborated with notable colleagues such as Shigehiro Takase and Masakuni Okuhara. These partnerships have fostered a creative environment wherein innovative ideas can flourish, leading to the successful realization of multiple patent applications that contribute to the scientific community.

Conclusion

Masanori Okamoto stands out as a prominent figure in pharmaceutical innovation. His dedication to research and development has resulted in numerous patents that benefit the health sector. As he continues to explore new avenues in medicine, Okamoto's work will likely inspire future advancements in pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…